Edition:
United Kingdom

Ucb SA (UCB.BR)

UCB.BR on Brussels Stock Exchange

70.30EUR
18 Apr 2019
Change (% chg)

€-1.00 (-1.40%)
Prev Close
€71.30
Open
€71.42
Day's High
€72.04
Day's Low
€70.30
Volume
406,387
Avg. Vol
359,373
52-wk High
€81.48
52-wk Low
€60.08

About

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia,... (more)

Overall

Beta: 0.67
Market Cap(Mil.): €13,673.75
Shares Outstanding(Mil.): 194.51
Dividend: 1.21
Yield (%): 1.17

Financials

  UCB.BR Industry Sector
P/E (TTM): 16.72 62.06 62.40
EPS (TTM): 4.20 -- --
ROI: 9.95 12.17 11.78
ROE: 13.07 13.11 12.61

Drugmaker UCB backs Brexit Britain with 1 billion pound investment

LONDON Belgian drugmaker UCB expects to invest about 1 billion pounds in Britain over the next five years, throwing its support behind the country's life sciences sector despite Brexit uncertainty.

05 Dec 2018

Earnings vs. Estimates